Personal profile
Headline
PROFESSOR Medicine, Hematology and Medical Oncology PROFESSOR Pediatrics
Biography
My clinical practice focuses exclusively on patients (both adult and pediatric) who undergo BMT and overlaps with my clinical research. I have designed, conducted, analyzed, and authored multiple clinical trials and data analyses of clinical GVHD, specifically, and clinical BMT, broadly. My long term goal is to improve outcomes for patients who undergo BMT by designing and conducting high impact clinical trials. I co-direct the Mount Sinai Acute GVHD International Consortium [MAGIC] with Dr. James Ferrara. This international consortium provides the opportunity to develop and test innovative treatment approaches for allogeneic BMT patients.
Fingerprint
Dive into the research topics where John Levine is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Differential effects of GVHD therapies on intestinal epithelium
Utrero-Rico, A., Kapoor, U., Berrios, B., Morales, G., Levine, J. E., Prado-Acosta, M. & Ferrara, J. L. M., 14 Apr 2026, In: Blood advances. 10, 7, p. 2431-2440 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Performance of Treatment Response Assessment at Day 7 by Baseline Acute Graft-versus-Host Disease Severity
Louloudis, I. E., Chen, Y. B., Spyrou, N., Alousi, A., Katsivelos, N., Ayuk, F., Weber, D., Hogan, W. J., Etra, A. M., Qayed, M., Aguayo-Hiraldo, P., Akahoshi, Y., Malki, M. M. A., Bolaños-Meade, J., Chanswangphuwana, C., Diniz, M., Eder, M., Hexner, E., Kitko, C. L. & Kraus, S. & 14 others, , Jan 2026, In: Transplantation and Cellular Therapy. 32, 1, p. 63.e1-63.e11Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
18 F-FLT PET and Blood-based Biomarkers for Identifying Gastrointestinal Graft versus Host Disease after Allogeneic Cell Transplantation
Holter-Chakrabarty, J., McNally, L., Levine, J., Ferrara, J., Vesely, S. K., Kanakry, C. G., Garwe, T., Han, Z., Pandey, M., Glover, J., Wen, Y., Gress, R. & Williams, K. M., 2025, In: Radiology: Imaging Cancer. 7, 1, e240096.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
AML biology matters, so should we transplant ASAP?
Levine, J. E., 6 Nov 2025, In: Blood. 146, 19, p. 2275-2276 2 p.Research output: Contribution to journal › Editorial
Open Access -
A Randomized Clinical Trial Evaluating Lactiplantibacillus Plantarum for the Prevention of GI aGvHD: A Report From the Children's Oncology Group (ACCL1633)
Ladas, E. J., Collier, W., Park, H., Auletta, J. J., Dvorak, C. C., August, A., Esbenshade, A. J., Bhatia, M., Fisher, B. T., Levine, J. E., Pollock, B. H., Uhlemann, A. C., Verneris, M. R., Walters, M., Yu, L. & Nieder, M., Jul 2025, In: Transplantation and Cellular Therapy. 31, 7, p. 452.e1-452.e12Research output: Contribution to journal › Article › peer-review
3 Scopus citations
Press/Media
-
The eRulemaking Program - 20260423 4-MW-Mussels fCH Literature-Cited
27/04/26
1 item of Media coverage
Press/Media
-
-
End-of-Quarter Synopsis Monthly : Mesoblast (MSB: $A2.72) increases in December 2025
31/12/25
1 item of Media coverage
Press/Media
-
Mesoblast to launch pivotal adult trial for cell therapy in severe steroid-refractory GVHD
24/11/25
1 item of Media coverage
Press/Media